(Q30500080)

19 October 2017

Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance (English)

1 reference

19 October 2017

1 reference

1 reference

1 reference

10

Robert L Vessella

1 reference

19 October 2017

9

Jiaoti Huang

1 reference

19 October 2017

Hiroshi Tanaka

1

1 reference

19 October 2017

Evelyn Kono

2

1 reference

19 October 2017

Chau P Tran

3

1 reference

19 October 2017

Hideyo Miyazaki

4

1 reference

19 October 2017

Joyce Yamashiro

5

1 reference

19 October 2017

Tatsuya Shimomura

6

1 reference

19 October 2017

Ladan Fazli

7

1 reference

19 October 2017

Robert Wada

8

1 reference

19 October 2017

Jaibin An

11

1 reference

19 October 2017

Steven Horvath

12

1 reference

19 October 2017

Martin Gleave

13

1 reference

19 October 2017

Matthew B Rettig

14

1 reference

19 October 2017

Zev A Wainberg

15

1 reference

19 October 2017

Robert E Reiter

16

1 reference

19 October 2017

language of work or name

English

0 references

publication date

7 November 2010

1 reference

19 October 2017

1 reference

19 October 2017

16

1 reference

19 October 2017

12

1 reference

19 October 2017

1414-1420

1 reference

Signed weighted gene co-expression network analysis of transcriptional regulation in murine embryonic stem cells

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Antitumor activity with CYP17 blockade indicates that castration-resistant prostate cancer frequently remains hormone driven.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Emerging therapies in castrate-resistant prostate cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Targeting Clusterin in prostate cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Molecular biology of androgen-independent prostate cancer: the role of the androgen receptor pathway.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

The epithelial-mesenchymal transition generates cells with properties of stem cells

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Androgen receptor and invasion in prostate cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Stem cells in prostate cancer: resolving the castrate-resistant conundrum and implications for hormonal therapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Akt-regulated pathways in prostate cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Beyond simple castration: targeting the molecular basis of treatment resistance in advanced prostate cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Reg IV: a promising marker of hormone refractory metastatic prostate cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Molecular determinants of resistance to antiandrogen therapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Androgen receptor involvement in the progression of prostate cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

N-Cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

The biology of hormone refractory prostate cancer. Why does it develop?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Cardiac-Specific Loss of N-Cadherin Leads to Alteration in Connexins With Conduction Slowing and Arrhythmogenesis

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Signal transduction from N-cadherin increases Bcl-2. Regulation of the phosphatidylinositol 3-kinase/Akt pathway by homophilic adhesion and actin cytoskeletal organization

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088104

Cadherin switching in human prostate cancer progression

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21057494

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

N-cadherin switching occurs in high Gleason grade prostate cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21057494

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NM.2236

1 reference

19 October 2017

1 reference

19 October 2017

PubMed publication ID

21057494

1 reference